Chondrogenic Neoplasm — Trials

Chondrogenic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

89 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05266196	A Rollover Protocol to Allow for Continued Access to the LSD1 Inhibitor Seclidemstat (SP-2577)	unknown	Phase 1 / Phase 2	10	Salarius Pharmaceuticals, LLCINDUSTRY	1	Aug 1, 2023	clinicaltrials
NCT05193188	A Study of Anlotinib Combined With or Without PD-1 Antibody on Unresectable High-grade Chondrosarcoma	unknown	Phase 2	70	Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER	1	Feb 16, 2023